Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection-Reference-Cited by-同舟云学术

Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection

Published:2020-01-15 Issue:1 Volume:15 Page:e0227440
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jun Baek Gyu^ORCID,Lee Woong Cheul,Jang Jae Young^ORCID,Jeong Soung Won,Chang Young,Lee Sae Hwan,Kim Young don,Kim Sang Gyune,Cheon Gab Jin,Kim Young Seok^ORCID,Kim Hong Soo,Jin So Young

Funder

This work was supported by the Soonchunhyang University Research Fund.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Management of hepatocellular carcinoma: an update;American Association for the Study of Liver D;Hepatology,2011

2. Global cancer statistics;A Jemal;CA: a cancer journal for clinicians,2011

3. Hepatocellular carcinoma;JM Llovet;Lancet,2003

4. Hepatocellular carcinoma: current management and perspectives for the future;NN Rahbari;Annals of surgery,2011

5. Resection and liver transplantation for hepatocellular carcinoma;JM Llovet;Seminars in liver disease,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma;Clinics and Research in Hepatology and Gastroenterology;2021-11

2. Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor;Journal of Cancer Research and Clinical Oncology;2021-06-22

3. Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets;Frontiers in Pharmacology;2021-04-15